Shattuck lecture - Medical and societal consequences of the human genome project

New England Journal of Medicine

Volumn 341, Issue 1, 1999, Pages 28-37

  Collins, Francis S ^a  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

CAENORHABDITIS ELEGANS; DNA POLYMORPHISM; DNA SEQUENCE; GENE ISOLATION; GENETIC ANALYSIS; GENETIC DISORDER; GENOME; HUMAN; LEGAL ASPECT; MEDICAL ETHICS; MEDICAL TECHNOLOGY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SOCIAL ASPECT;

CONFIDENTIALITY; EDUCATION, PROFESSIONAL; GENE THERAPY; GENETIC COUNSELING; GENETIC DISEASES, INBORN; GENETIC SCREENING; GENOME, HUMAN; HISTORY, 20TH CENTURY; HUMAN GENOME PROJECT; HUMANS; NATIONAL INSTITUTES OF HEALTH (U.S.); RISK ASSESSMENT; UNITED STATES;

EID: 0033168459     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199907013410106     Document Type: Review

References (45)

1. National Research Council Committee on Mapping and Sequencing the Human Genome. Mapping and sequencing the human genome. Washington, D.C.: National Academy Press, 1988.
2. Department of Health and Human Services, Department of Energy. Understanding our genetic inheritance: the U.S. Human Genome Project: the first five years: FY 1991-1995. Washington, D.C.: Government Printing Office, 1990. (NIH publication no. 90-1590.)
3. Collins FS, Patrinos A, Jordan E, Chakravarti A, Gesteland R, Walters I. New goals for the U.S. Human Genome Project: 1998-2003. Science 1998;282:682-9.
4. Murray JC, Buetow KH, Weber JL, et al. A comprehensive human linkage map with centimorgan density. Science 1994;265:2049-54.
5. Deloukas P, Schuler GD, Gyapay G, et al. A physical map of 30,000 human genes. Science 1998;282:744-6.
6. Collins FS, Galas D. A new five-year plan for the U.S. Human Genome Project. Science 1993;262:43-6.
7. The yeast genome directory. Nature 1997;387:Suppl:5.
8. Blattner FR, Plunkett G III, Bloch CA, et al. The complete genome sequence of Escherichia coli K-12. Science 1997;277:1453-74.
9. Collins FS. Positional cloning: let's not call it reverse anymore. Nat Genet 1992;1:3-6.
10. Idem. Positional cloning moves from perditional to traditional. Nat Genet 1995;9:347-50. [Erratum, Nat Genet 1995;11:104.]
11. Polymeropoulos MH, Lavedan C, Leroy E, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 1997;276:2045-7.
12. Gasser T, Muller-Myhsok B, Wszolek ZK, et al. A susceptibility locus for Parkinson's disease maps to chromosome 2p13. Nat Genet 1998;18: 262-5.
13. Jones AC, Yamamura Y, Almasy L, et al. Autosomal recessive juvenile parkinsonism maps to 6q25.2-q27 in four ethnic groups: detailed genetic mapping of the linked region. Am J Hum Genet 1998;63:80-7.
14. Leroy E, Boyer R, Auburger G, et al. The ubiquitin pathway in Parkinson's disease. Nature 1998;395:451-2.
15. Ueda K, Fukushima H, Masliah E, et al. Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc Natl Acad Sci U S A 1993;90:11282-6.
16. Burke W, Thomson E, Khoury MJ, et al. Hereditary hemochromatosis: gene discovery and its implications for population-based screening. JAMA 1998;280:172-8.
17. Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996; 13:399-408.
18. Miki Y, Swensen J, Shattuck-Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994; 226:66-71.
19. Wooster R, Bignell G, Lancaster J, et al. Identification of the breast cancer susceptibility gene BRCA2. Nature 1995;378:789-92. [Erratum, Nature 1996;379:749.]
20. Yamagata K, Furuta H, Oda O, et al. Mutations in the hepatocyte nuclear factor-4α gene in maturity-onset diabetes of the young (MODY 1). Nature 1996;384:458-60.
21. Froguel P, Zouali H, Vionnet N, et al. Familial hyperglycemia due to mutations in glucokinase: definition of a subtype of diabetes mellitus. N Engl J Med 1993;328:697-702.
22. Yamagata K, Oda N, Kaisaki PJ, et al. Mutations in the hepatocyte nuclear factor-1α gene in maturity-onset diabetes of the young (MODY3). Nature 1996;384:455-8.
23. Fishel R, Lescoe MK, Rao MR, et al. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 1993;75:1027-38. [Erratum, Cell 1994;77:167]
24. Leach FS, Nicolaides NC, Papadopoulos N, et al. Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 1993;75:1215-25.
25. Papadopoulos N, Nicolaides NC, Wei YF, et al. Mutation of a mutL homolog in hereditary colon cancer. Science 1994;263:1625-9.
26. Schafer AJ, Hawkins JR. DNA variation and the future of human genetics. Nat Biotechnol 1998;16:33-9.
27. Collins FS, Guyer MS, Charkravarti A. Variations on a theme: cataloging human DNA sequence variation. Science 1997;278:1580-1.
28. Wang DG, Fan J-B, Siao C-J, et al. Large-scale identification, mapping and gcnotyping of single-nucleotide polymorphisms in the human genome. Science 1998;280:1077-82.
29. Hacia JG, Brody LC, Chee MS, Fodor SP, Collins FS. Detection of heterozygous mutations in BRCA1 using high density oligonucleotide arrays and two-colour fluorescence analysis. Nat Genet 1996;14:441-7.
30. DeRisi J, Penland L, Brown PO, et al. Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat Genet 1996;14:457-60.
31. Hacia JG, Makalowski W, Edgemon K, et al. Evolutionary sequence comparisons using high-density oligonucleotide arrays. Nat Genet 1998; 18:155-8.
32. Winzeler EA, Richards DR, Conway AR, et al. Direct allelic variation scanning of the yeast genome. Science 1998;281:1194-7
33. Kononen J, Bubendorf L, Kallioniemi A, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 1998; 4:844-7.
34. Poirier J, Delisle M-C, Quirion R, et al. Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease. Proc Natl Acad Sci U S A 1995;92:12260-4.
35. Kuivenhoven JA, Jukema JW, Zwinderman AH, et al. The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. N Engl J Med 1998;338:86-93.
36. Martinelli I, Sacchi E, Landi G, Taioli E, Duca F, Mannucci PM. High risk of cerebral-vein thrombosis in carriers of a prothrombin gene mutation and in users of oral contraceptives. N Engl J Med 1998;338:1793-7.
37. New medicines in development: biotechnology 1998. Washington, D.C.: Pharmaceutical Research and Manufacturers of America, 1998:35.
38. Rubenstein RC, Zeitlin PL. A pilot clinical trial of oral sodium 4-phenylbutyrate (Buphenyl) in deltaF508-homozygous cystic fibrosis patients: partial restoration of nasal epithelial CFTR function. Am J Respir Crit Care Med 1998;157:484-90.
39. Hudson KL, Rothenberg KH, Andrews LB, Kahn MJ, Collins FS. Genetic discrimination and health insurance: an urgent need for reform. Science 1995;270:391-3.
40. Rothenberg K, Fuller B, Rothstein M, et al. Genetic information and the workplace: legislative approaches and policy challenges. Science 1997; 275:1755-7.
41. Compliance manual. Section 902. Washington, D.C.: Equal Employment Opportunity Commission, March 15, 1995.
42. Holtzman NA, Watson MS, eds. Promoting safe and effective genetic testing in the United States: final report of the Task Force on Genetic Testing. Baltimore: Johns Hopkins University Press, 1998.
43. Scanlon C, Fibison W. Managing genetic information: implications for nursing practice. Washington, D.C.: American Nurses Publishing, 1995:1-50.
44. National Center for Genome Resources. National survey of public and stakeholders' attitudes and awareness of genetic issues. Washington, D.C.: Schulman, Ronca, and Bucuvalas, 1996.
45. Osler W. Chauvinism in medicine. Montreal Med J 1902;31:684-99.